World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02721862
Date of registration: 18/03/2016
Prospective Registration: No
Primary sponsor: American University of Beirut Medical Center
Public title: Effectiveness of Ursodeoxycholic Acid Use in the Prevention of Gallstone Formation After Sleeve Gastrectomy
Scientific title: Effectiveness of Ursodeoxycholic Acid Use in the Prevention of Gallstone Formation After Sleeve Gastrectomy: A Prospective Randomized Multicenter Placebo-Controlled Trial
Date of first enrolment: March 2016
Target sample size: 100
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02721862
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  Phase 3
Countries of recruitment
Lebanon
Contacts
Name:     Ramzi S. Alami, MD, FACS
Address: 
Telephone: +961-1-350000
Email: ra204@aub.edu.lb
Affiliation: 
Name:     Ramzi S. Alami, Md, FACS
Address: 
Telephone:
Email:
Affiliation:  American University of Beirut Medical Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- Obese patients (body mass index > 35 kg/m2) undergoing laparoscopic sleeve gastrectomy
as a primary treatment for their obesity.

- No gallstone disease on initial ultrasounds

- No previous cholecystectomy

Exclusion Criteria:

- Bariatric patients with gallbladder stones on baseline ultrasound examination.

- Patients with a previous cholecystectomy



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Cholelithiasis
Intervention(s)
Radiation: Gallbladder Ultrasound
Drug: Placebo
Drug: Ursodeoxycholic Acid
Primary Outcome(s)
Incidence of gallstone formation after laparoscopic sleeve gastrectomy [Time Frame: At 6 months to 18 months after laparoscopic sleeve gastrectomy]
Secondary Outcome(s)
Secondary ID(s)
SUR.RA.01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Makassed General Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history